Cargando…

Risk factors for development of nephropathy in patients with a diabetic Charcot foot

OBJECTIVE: Charcot foot is a rare complication to neuropathy and can cause severe foot deformities and ulcerations, which often require prolonged antibiotical treatment. The objective of this retrospective study was to investigate whether this treatment is associated to impaired renal function. RESU...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansen, Rasmus Bo, Holstein, Per E., Jørgensen, Bo, Møller, Klaus Kirketerp, Svendsen, Ole Lander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557477/
https://www.ncbi.nlm.nih.gov/pubmed/34717731
http://dx.doi.org/10.1186/s13104-021-05811-5
_version_ 1784592379571863552
author Jansen, Rasmus Bo
Holstein, Per E.
Jørgensen, Bo
Møller, Klaus Kirketerp
Svendsen, Ole Lander
author_facet Jansen, Rasmus Bo
Holstein, Per E.
Jørgensen, Bo
Møller, Klaus Kirketerp
Svendsen, Ole Lander
author_sort Jansen, Rasmus Bo
collection PubMed
description OBJECTIVE: Charcot foot is a rare complication to neuropathy and can cause severe foot deformities and ulcerations, which often require prolonged antibiotical treatment. The objective of this retrospective study was to investigate whether this treatment is associated to impaired renal function. RESULTS: In total, 163 patients were included, of whom 105 (64%) had received β-lactam antibiotics for a mean total duration of 13.0 months. There was a significant increase in the urine albumin/creatinine ratio in the group that received antibiotics (p = 0.017), and the use of antibiotics was associated to a subsequent diagnosis of nephropathy (p = 0.01). Patients treated with antibiotics had a 21.9% risk of developing subsequent nephropathy versus 5.2% for patients not treated with antibiotics. We suggest increased awareness on signs of nephropathy in patients with severe Charcot foot. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13104-021-05811-5.
format Online
Article
Text
id pubmed-8557477
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85574772021-11-01 Risk factors for development of nephropathy in patients with a diabetic Charcot foot Jansen, Rasmus Bo Holstein, Per E. Jørgensen, Bo Møller, Klaus Kirketerp Svendsen, Ole Lander BMC Res Notes Research Note OBJECTIVE: Charcot foot is a rare complication to neuropathy and can cause severe foot deformities and ulcerations, which often require prolonged antibiotical treatment. The objective of this retrospective study was to investigate whether this treatment is associated to impaired renal function. RESULTS: In total, 163 patients were included, of whom 105 (64%) had received β-lactam antibiotics for a mean total duration of 13.0 months. There was a significant increase in the urine albumin/creatinine ratio in the group that received antibiotics (p = 0.017), and the use of antibiotics was associated to a subsequent diagnosis of nephropathy (p = 0.01). Patients treated with antibiotics had a 21.9% risk of developing subsequent nephropathy versus 5.2% for patients not treated with antibiotics. We suggest increased awareness on signs of nephropathy in patients with severe Charcot foot. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13104-021-05811-5. BioMed Central 2021-10-30 /pmc/articles/PMC8557477/ /pubmed/34717731 http://dx.doi.org/10.1186/s13104-021-05811-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Note
Jansen, Rasmus Bo
Holstein, Per E.
Jørgensen, Bo
Møller, Klaus Kirketerp
Svendsen, Ole Lander
Risk factors for development of nephropathy in patients with a diabetic Charcot foot
title Risk factors for development of nephropathy in patients with a diabetic Charcot foot
title_full Risk factors for development of nephropathy in patients with a diabetic Charcot foot
title_fullStr Risk factors for development of nephropathy in patients with a diabetic Charcot foot
title_full_unstemmed Risk factors for development of nephropathy in patients with a diabetic Charcot foot
title_short Risk factors for development of nephropathy in patients with a diabetic Charcot foot
title_sort risk factors for development of nephropathy in patients with a diabetic charcot foot
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557477/
https://www.ncbi.nlm.nih.gov/pubmed/34717731
http://dx.doi.org/10.1186/s13104-021-05811-5
work_keys_str_mv AT jansenrasmusbo riskfactorsfordevelopmentofnephropathyinpatientswithadiabeticcharcotfoot
AT holsteinpere riskfactorsfordevelopmentofnephropathyinpatientswithadiabeticcharcotfoot
AT jørgensenbo riskfactorsfordevelopmentofnephropathyinpatientswithadiabeticcharcotfoot
AT møllerklauskirketerp riskfactorsfordevelopmentofnephropathyinpatientswithadiabeticcharcotfoot
AT svendsenolelander riskfactorsfordevelopmentofnephropathyinpatientswithadiabeticcharcotfoot